Free lookups: 1/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
1 of 3 free lookups remaining Upgrade
New search Medicine profile Sulphur/Salicylic AcidSulphur/ Aluminium Chlorhydroxide /Methyl Prednisolone / Neomycin Sulphate

Clinical medicine profile

Sulphur/Salicylic AcidSulphur/ Aluminium Chlorhydroxide /Methyl Prednisolone / Neomycin Sulphate

alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC], Catecholamine [EPC]

POM
Evidence state Source-linked Review date not recorded
Route
ORAL / IV / IM / INHALED / TOPICAL / NASAL / OPHTHALMIC
Schedule
POM
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

Contraindications

  • Systemic fungal infections (untreated) for systemic steroids.
  • Live vaccines with significant immunosuppression.
  • Hypersensitivity.
  • Topical: untreated skin infection at site (relative).

Precautions

  • WARNINGS: If pregnant or breast-feeding, ask a health professional before use.
  • Keep out of reach of children.
  • In case of overdose, get medical help or contact a Poison Control Center right away.
  • Do not use if tamper evident seal is broken or missing.
  • Store in a cool, dry place.
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

DIRECTIONS: Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

Paediatric

See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.

Renal

Fluid retention/hypertension — care in renal disease.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Hepatic

Prednisone needs hepatic activation to prednisolone.

03 Clinical use

Use, effects & interactions

Indications

  • INDICATIONS: May temporarily relieve sinus congestion, runny nose, and sneezing.** **Claims based on traditional homeopathic practice, not accepted medical evidence.
  • Not FDA evaluated.
  • Clinical selection for Sulphur/Salicylic AcidSulphur/ Aluminium Chlorhydroxide /Methyl Prednisolone / Neomycin Sulphate should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC.
  • Class context: alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC], Catecholamine [EPC].
  • Confirm site-specific dose, duration and monitoring before prescribing.

Adverse effects

  • [From component Salicylic Acid /Flumetasone Pivalate] Local irritation e.g burning sensation and itching, erythema rare, dryness of the skin, aggravation of concurrent untreated infections, thinning of the skin (this may be reversible), loss of skin elasticity, folliculitis, change in skin pigmentation, telangiectasia, purpura and steroid acne, increased growth of hair, severe pituitary-adrenal axis suppression and hypercotism, cushoid state, growth retardation, benign intra-cranial hypertension.
  • Fixed-dose/multi-ingredient product.
  • Clinical details partially inherited from component monographs: Salicylic Acid /Flumetasone Pivalate, Methyl prednisolone.
  • Confirm combination SmPC for exact dosing.
04 Pharmacology

Mechanism & disposition

Combination product.

Combination product.Component mechanism (Methyl prednisolone):…These complexes then enter the cell nucleu…
Read complete mechanism

Combination product. Component mechanism (Methyl prednisolone): It diffuses across cell membranes and forms a complex with specific cytoplasmic receptors. These complexes then enter the cell nucleus, binds to DNA, and stimulate transcription of messenger RNA [mRNA]. Messenger RNA leads to protein synthesis of various enzymes that are responsible for the effects of systemic corticosteroids. Betamethasone may suppress transcription of mRNA in some cells like lymphocytes.

Onset

Hours–days

Duration

Agent and route dependent

Route

ORAL / IV / IM / INHALED / TOPICAL / NASAL / OPHTHALMIC

05 Special populations

Pregnancy, lactation & diet

Pregnancy

[Sulphur] Used when maternal benefit clear; prefer agents with better obstetric data (e.g. prednisolone). Document risk–benefit. [Salicylic AcidSulphur] Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist. [Methyl Prednisolone] Used when maternal benefit clear; prefer agents with better obstetric data (e.g. prednisolone). Document risk–benefit.

Lactation

[Sulphur] Low-dose systemic often compatible; time feeds if high dose — agent-specific. [Salicylic AcidSulphur] Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data. [Methyl Prednisolone] Low-dose systemic often compatible; time feeds if high dose — agent-specific.

06 Kenya market

Brands & loaded prices

From
Median
Listings0
BrandManufacturerPackObserved price
No reviewed brand listings are linked yet.
07 Provenance

Sources & review state

Primary sourceLocal active-ingredient clinical extract; FDA drug label via OpenFDA/DailyMed; Component monographs (multi-source pipeline); Professional class pharmacology (Corticosteroid)
Last reviewedNot recorded
EvidenceSource-linked
Open source document ↗

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.